Crossref
Real-world evidence for immune checkpoint inhibitors in extensive-stage small cell lung cancer
AME Clinical Trials Review · 2024
DOI: 10.21037/actr-23-32 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Clinical Trials Review, 2024. Verfasst von Andrea Bianco und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bianco, A., & D’Agnano, V. (2024). Real-world evidence for immune checkpoint inhibitors in extensive-stage small cell lung cancer. AME Clinical Trials Review. https://doi.org/10.21037/actr-23-32
Vancouver
Bianco A, D’Agnano V. Real-world evidence for immune checkpoint inhibitors in extensive-stage small cell lung cancer. AME Clinical Trials Review. 2024. doi:10.21037/actr-23-32
BibTeX
@article{Bianco2024,
author = {Bianco, Andrea and D’Agnano, Vito},
title = {Real-world evidence for immune checkpoint inhibitors in extensive-stage small cell lung cancer},
journal = {AME Clinical Trials Review},
year = {2024},
doi = {10.21037/actr-23-32}
}
EUVIMED